Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

Abstract Background Immune checkpoint inhibitors (ICIs) have achieved unprecedented success in cancer treatment over the past decade. The application of ICIs hasled to the discovery of various types of immune-related adverse events (irAEs). Here, we report a case of fatal myositis and spontaneous ha...

Full description

Bibliographic Details
Main Authors: Yuan Liu, Zhi Liu, Xuejun Zeng, Chunmei Bai, Lin Chen, Songbai Lin, Xinlun Tian
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Cancer
Subjects:
Immune checkpoint inhibitors
Ipilimumab
Nivolumab
Myositis
Haematoma
Immune-related adverse event
Online Access:https://doi.org/10.1186/s12885-019-6372-z

Internet

https://doi.org/10.1186/s12885-019-6372-z

Similar Items